{"name":"Castle Creek Biosciences, LLC.","slug":"castle-creek-biosciences-llc","ticker":"","exchange":"","domain":"castlecreekllc.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"D-Fi","genericName":"D-Fi","slug":"d-fi","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"D-Fi","genericName":"D-Fi","slug":"d-fi","phase":"phase_3","mechanism":"D-Fi is a monoclonal antibody that targets an unspecified mechanism.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-12","type":"pipeline","source":"GlobeNewswire","summary":"Pharmaceutical and Biotechnology Royalty Rates Agreements - GlobeNewswire","headline":"Pharmaceutical and Biotechnology Royalty Rates Agreements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gJBVV95cUxOckJoUElwamUxbzFfODdxbnBkdHRyMW1YVGc0eHlZMXBEb2d0a3pEOXhCYVF0WTB2SmhPb295TFd0MTNrSS1YTUxjOExjNnIzRUpkNkJDbXVhRUNJNXM2alVRdEYxQUtyT3FLR0kxLVB6V0Vkel9rZGdQdFVsSkV5Xy0xRnFHZUdGTUVvLXpidWYtdFpRSHlxNEM3SUk3MmN4R05Za3JNa2N2dHFWbGFXNlpCbjVBZXhjM3FoT19hb24wdXFkaXN6aHVEN0JQU3RUQ2FEWnhJdWtPbjZQa0oxRVdfcEJEVXh2U0UzMzBmSmNJY05sNV80VjQxLTRST24xTkctMFVrUXBhcjVEaVEydXpseTNRTHlwckdzdnotbHFZMzhRRkhrNEk0UDQ4Z0lJMWhhU1VlWWR2R041aHY1M2xaMVpFbjE4RUFlRWJ3NjdmcHFiVm55VTV6R25MWE9SNHBFSjZ2SGxGXy1zQU4zVkJn?oc=5","date":"2026-02-26","type":"pipeline","source":"GlobeNewswire","summary":"Cell & Gene Therapy Drug Delivery Devices Market - Global - GlobeNewswire","headline":"Cell & Gene Therapy Drug Delivery Devices Market - Global","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBScXRtQ0tnTHAtQ1RNeTQwUm9HcmNXWXVJUzg0NGo4b2dUVnVYSS01ekpBUlpXa1J0bDlpWlhham5ubzhYZXh4dW5yanlVR19ZSnc?oc=5","date":"2025-06-06","type":"trial","source":"Endpoints News","summary":"IPO Tracker (2021) - Endpoints News","headline":"IPO Tracker (2021)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxPTGFlNmx0T2ZSSXpIclNPMjdnLVUxX3JkUHB1REtfbzdhcktLbkI5X3pVT0NWYXFKSGNFT1g5alRCNTlXOUs4R040V28tTXZrNXNrVzROYlFTTUtsMDQweldLYnY3cEZ2eU16ZjdkWnJmcENhaURsVTZ0MlJoYWpWd3lMdlMtR0thY3BpZEVaV3JWdFpWSm81ZjhUdnZSaEhyTDFDdjdzNF9pMC1IcmlZQjcwcWJxRTlsY2M0NHE1TUlxVDNPMDZ3RklpcjRCMHNRVnF5VzQzR3BUVWNyZF9JWUhyc210TzR6YzZjakp6cE9vRzIxOVRNWlVR?oc=5","date":"2025-05-22","type":"regulatory","source":"prnewswire.com","summary":"ZEVASKYN Approval Positions Abeona as Emerging Player in Dystrophic Epidermolysis Bullosa Market | DelveInsight - prnewswire.com","headline":"ZEVASKYN Approval Positions Abeona as Emerging Player in Dystrophic Epidermolysis Bullosa Market | DelveInsight","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxOZ2ZCSGFOLV9qbUhsdDJVdnA0MTNPdFpUZENOS1RRQWFNUmppYkpoX2hXYWNObTNFejRFekdWVXBlZ3pBTm1SZUE2NHE4amNISGhHUmRWTXJRSmFhR2NReThueUFHX19EMll6bWdzVVZGa3E5Z283cGEzU0tyUDdBYTg2UmxWZGRmNVB3T2xoV0p3M2pjQmRjbE5idTRnQlJRX1Zrekgtc1VvYzZ2SEp2UGJOTGdWUUQwckRQdGpCUlI4SmdvS2pHRHhaSDhsYUJyczQzT2otVUY?oc=5","date":"2025-02-25","type":"pipeline","source":"GlobeNewswire","summary":"Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences - GlobeNewswire","headline":"Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxPNmlLcDY5aTUxYUtZbFVWamxmOE45RmFWbFl0UTg2VnZjVldWZDBLeUxWVTdqMVUxamplR2FBNzdKZnBGOTN2NGxuZ1JJTVhzaWZoNk55U1UwNXZzdHBiaTRuOUhnejhLejRSQ2F0Qzd0clNJeFI0WFZ5T0lOdDlpVm80ZzFWREpZVU5fYm9wd0s0ZjR4b0wwWVBZOEk1Z0RUaElxN29jcVNWTTE4aU9FMFRvX05qNFgwOXlfQUwtekxZMVlSVVJMcGE0MXBPUlhfeTF0RlFITVpKMGNSTndwaTRSZU9ONmVSYk5jcjNrQmtYMmxwREtXS3VRWUIwSDU5VVFXZ2tfMTI3a1VDbnlrcWMwYzI3Q3NsZFVPT3RBUjVVU25FQWxDRUJ0TFpBWk1uR1hiaWFLRjlEM1NVbENqSEkzbVpoQmFqQXc?oc=5","date":"2024-11-13","type":"pipeline","source":"prnewswire.com","summary":"Cell and Gene Therapy Market to Grow by USD 6.56 Billion (2024-2028), Driven by Rising Prevalence of Chronic Diseases, AI-Powered Report Explores Market Evolution - Technavio - prnewswire.com","headline":"Cell and Gene Therapy Market to Grow by USD 6.56 Billion (2024-2028), Driven by Rising Prevalence of Chronic Diseases, A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOaG5oYmUxOXdlRFRRQXMydEc0emVSWXhMUV9CSmJmMUdMUkVKSElaZjlOQmRVeXBOU1lia3huTl90d2wtS2lVSVpYb0Z2eWdoSG5Mb2hDbURrOUFiTFRjMmlvNnFaSGFRazZOekVvb1c0ck5sMnJLYWZ4dHhaMFVVYW9qWU5HTGNZU194S0wtaw?oc=5","date":"2024-05-29","type":"pipeline","source":"drugdiscoverytrends.com","summary":"100 of the best-funded private healthcare and biotech companies - drugdiscoverytrends.com","headline":"100 of the best-funded private healthcare and biotech companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxQTkZGRzU3VmxZdlhlU3BEeUV3NmlrYTZkR1JLTnNSRkd6T094cVJ4VVB5UVVaTE1qNUJmeU5YcjZkeEdFZTNfWGp0U1pSZElYQ0JOeEFMRFAzS2FSS09oalNWZVVLcHBxTWd0RnUySmdSLWtGNWdlV0V6RUM2ZDRXaEpUa01KM0otZ3JMV3I3Q2ZWMlJYUWRtZUFGRlRaOVdBYldJZkN1WWlwWWptSzd1OXM4clBlNGpkUnE0SFlyb1VpUl9NUDBxNmR2QUIxQmZZRUh0dGRtN2NGM3k1dHJlUll6T2MyRV8xZFBMS2RRWTdwZE0zNnZvbnRrb29PVDlaOER6Q1BkeUZjSDI5SllN?oc=5","date":"2022-10-14","type":"pipeline","source":"prnewswire.com","summary":"Cell and Gene Therapy Market Size to Grow by USD 9.97 Bn, Increasing Prevalence of Chronic Diseases to Drive Growth - Technavio - prnewswire.com","headline":"Cell and Gene Therapy Market Size to Grow by USD 9.97 Bn, Increasing Prevalence of Chronic Diseases to Drive Growth - Te","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOUzJRNVJ3bDQzNm1yRGlyLUpUUmctUUVwT3ZPZUZOM1NwaXQtMXBySzhVX2xtcTFjcV9pNTdDd3BRWEI0dURCZWpMbzZlVVJkQjVlY2dlQmJuVlJ3Y3VnVWVXajV6MjlwWGZSODk0NTZER2x2ZVBkNkh1bUxCQm1Md3lHclA0NUdncHlQeERaNjREOFdOWFpaVFpB?oc=5","date":"2020-05-09","type":"pipeline","source":"Philadelphia Magazine","summary":"9 Philly Companies on the Cutting Edge of Cell and Gene Therapy Innovation - Philadelphia Magazine","headline":"9 Philly Companies on the Cutting Edge of Cell and Gene Therapy Innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQZmFabDNiakptd1hqeXJ1cjUtMUlLRUtjQks4aEN6OHRjUWhfZTRQdDE1alhzWnNWZUxUMUtfYl8ycUNsWE52SEZqMV9DUU9iaWp6VDU4anJYSzBDUkE1VjJnT0hxa3h4Y2pyTlhCZlQzek9nY1ZFMGRfTDdRRDdGSEluSDBLd0JlY3RpUEtQb3duSEYzUVZLOGNtM3J2SnR3b1FYenBxdGVUN3hE?oc=5","date":"2019-04-22","type":"pipeline","source":"Fierce Biotech","summary":"Former Alkermes COO Robinson to head up ops at Paragon Biosciences - Fierce Biotech","headline":"Former Alkermes COO Robinson to head up ops at Paragon Biosciences","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}